"Legislation, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Laws concerned with manufacturing, dispensing, and marketing of drugs.
| Descriptor ID |
D007880
|
| MeSH Number(s) |
I01.880.604.605 N03.706.615.402
|
| Concept/Terms |
Legislation, Drug- Legislation, Drug
- Drug Laws
- Drug Law
- Law, Drug
- Laws, Drug
- Drug Legislation
Narcotic Laws- Narcotic Laws
- Law, Narcotic
- Laws, Narcotic
- Narcotic Law
|
Below are MeSH descriptors whose meaning is more general than "Legislation, Drug".
Below are MeSH descriptors whose meaning is more specific than "Legislation, Drug".
This graph shows the total number of publications written about "Legislation, Drug" by people in this website by year, and whether "Legislation, Drug" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Legislation, Drug" by people in Profiles.
-
The Best Pharmaceuticals for Children Act and Pediatric Research Equity Act reach the age of majority-An oncology perspective. Pediatr Blood Cancer. 2021 03; 68(3):e28871.
-
Probiotics and the Microbiome-How Can We Help Patients Make Sense of Probiotics? Gastroenterology. 2021 01; 160(2):614-623.
-
Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad. Am J Ophthalmol. 2016 09; 169:xiv-xvi.
-
Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation. Am J Med Sci. 2011 Nov; 342(5):356-64.
-
E-cigarettes: a rapidly growing Internet phenomenon. Ann Intern Med. 2010 Nov 02; 153(9):607-9.
-
Health care consequences of black-box warnings for antidepressants in the United States and Canada. Res Social Adm Pharm. 2010 Mar; 6(1):78-84.
-
Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine. J Am Pharm Assoc (2003). 2008 Jan-Feb; 48(1):52-7.
-
Pseudoephedrine laws in the US--are we doing enough? Ann Pharmacother. 2006 Jun; 40(6):1213-5.